PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Study Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer Treatments
- Conditions
- Colorectal Neoplasm
- Interventions
- Biological: CP-751, 871
- First Posted Date
- 2007-11-19
- Last Posted Date
- 2013-05-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 168
- Registration Number
- NCT00560560
- Locations
- 🇬🇧
Pfizer Investigational Site, Southampton, United Kingdom
Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- First Posted Date
- 2007-11-19
- Last Posted Date
- 2013-03-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 46
- Registration Number
- NCT00560573
- Locations
- 🇪🇸
Pfizer Investigational Site, Sevilla, Spain
Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
- First Posted Date
- 2007-11-19
- Last Posted Date
- 2015-10-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 138
- Registration Number
- NCT00560235
- Locations
- 🇬🇧
Pfizer Investigational Site, Oxford, United Kingdom
A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2007-11-16
- Last Posted Date
- 2018-10-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 230
- Registration Number
- NCT00559910
- Locations
- 🇬🇧
Pfizer Investigational Site, Edinburgh, United Kingdom
A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors
- First Posted Date
- 2007-11-14
- Last Posted Date
- 2015-10-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 70
- Registration Number
- NCT00557856
- Locations
- 🇺🇸
Medical University of South Carolina, Hollings Cancer Center, Charleston, South Carolina, United States
🇮🇹S.C Diagnostica Radiologica 2, Milano, Italy
🇮🇹S.C. Chirurgia Generale Indirizzo Oncologico 1 (epato-gastro-pancreatica), Milano, Italy
A Study Of PF-03732010 In Patients With Advanced Solid Tumors
- Conditions
- Neoplasms
- Interventions
- Drug: PF-03732010
- First Posted Date
- 2007-11-14
- Last Posted Date
- 2012-03-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 43
- Registration Number
- NCT00557505
- Locations
- 🇰🇷
Pfizer Investigational Site, Seoul, Korea, Republic of
A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents
- First Posted Date
- 2007-11-12
- Last Posted Date
- 2016-05-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 26
- Registration Number
- NCT00556998
- Locations
- 🇺🇸
Pfizer Investigational Site, Houston, Texas, United States
Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer
- Conditions
- Stomach Neoplasms
- Interventions
- First Posted Date
- 2007-11-09
- Last Posted Date
- 2011-12-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 34
- Registration Number
- NCT00555672
- Locations
- 🇪🇸
Pfizer Investigational Site, Madrid, Spain
Study Of JAK3 Inhibitor For The Prevention Of Acute Rejection In Kidney Transplant Patients
- First Posted Date
- 2007-11-09
- Last Posted Date
- 2008-05-30
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00556257
An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma.
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2007-11-09
- Last Posted Date
- 2015-03-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 53
- Registration Number
- NCT00555906
- Locations
- 🇺🇸
University of Kansas Cancer Center and Medical Pavilion, Westwood, Kansas, United States
🇺🇸Barnes-Jewish Hospital, St. Louis, Missouri, United States
🇺🇸Medical University of South Carolina, Charleston, South Carolina, United States